Proactive Investors interview with chairman Tim McCarthy – May 2019

29th May 2019 - 11:37 am

ImmuPharma PLC’s (LON:IMM) chairman Tim McCarthy tells Proactive London’s Andrew Scott discussions with potential partners are ongoing as they consider the best route forward for its lead drug Lupuzor™

 

Share this article